.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Dr. Alexandra Ehrens

Weitere Beteiligungen

26.09.2023
Poster
P-2-62
Corallopyronin A: successful non-GLP in vivo toxicity tests in rat and dog support continued development to first in human trials
Tropical and Emerging Infections
26.09.2023
Poster
P-2-98
Development of a physiologically based biopharmaceutics model for CorA and prediction of human pharmacokinetics and effective dose using enhanced formulation
Tropical and Emerging Infections
26.09.2023
15:20 – 15:30 8 Min. 2 Min.
Short Talk
S-6-3
The immune system contributes to treatment efficacy of the anthelmintic benzimidazole oxfendazole
Tropical and Emerging Infections